“The next frontier in advancing human health lies in our ability to safely and effectively modulate the gut microbiome.”
Pankaj Jay Pasricha, MD, co-founder
Dr. Pasricha co-founded P4 Microbiome in 2020.
Dr. Pasricha is a nationally renowned gastroenterologist and currently a Professor of Medicine and Neurosciences at John’s Hopkins. Previously, he was the Chief of Gastroenterology at Stanford University School of Medicine.
Dr. Pasricha served on the National Commission on Digestive Diseases, appointed by the US Congress to provide a roadmap for progress in gastrointestinal disorders. He is also the founding Chair of the Center for Gastrointestinal Innovation and Technology, a body created by the AGA (American Gastroenterological Association) for the promotion of technological innovation in this field. Dr. Pasricha also served on the FDA GI Drug Advisory Committee for several years.
Dr. Pasricha holds more than 50 patents issued or in process by the USPTO and has co-founded several companies within both the medtech and biotech. Furthermore, one of the companies Dr Pasricha founded, Apollo Endosurgery went public in 2022. His contributions to endoscopy include the use of botulinum toxin for GI disorders, cryotherapy, novel stents and the POEM procedure.
Dr. Pasricha is also:
Director of the Johns Hopkins Center for Neurogastroenterology
Director of the Amos Food, Body and Mind Center at Johns Hopkins
Professor in the Department of Neurosciences in the Johns Hopkins School of Medicine and at the Carey School of Business.
Author of more than 300 manuscripts and book chapters including contributions to Cecil Textbook of Medicine, Yamada Textbook of Gastroenterology, Goodman and Gilman’s Pharmacological Basis of Therapeutics and Uptodate
He has been the Associate Editor for Gastroenterology, the senior editorial advisor for Digestive Diseases and Sciences and has served as Associate Editor for the Journal of Pediatric Gastroenterology and Nutrition and Associate Editor for Gastrointestinal Endoscopy
Dr. Pasricha received the AGA Master’s Award for Outstanding Sustained Achievement in Gastroenterology and the “Nobility in Science” Award, National Pancreas Foundation. In addition, he has consistently been listed in Castle Connelly’s “America’s Top Doctors” as well as “Best Doctors” in America.
“The problem of gingivitis represents an insanely large unmet medical need in the US and around the world. A sustainable solution to this problem will significantly change the trajectory of health in a population.”
Phillip H. Phan, PhD, co-founder
Dr Phan co-founded P4 Microbiome in 2018. He is currently a full-time faculty member at the Johns Hopkins University.
In addition to his work with P4 Microbiome, Dr. Phan is the:
Alonzo and Virginia Decker Professor at the Johns Hopkins Carey Business School with joint appointment as Professor in the Department of Medicine
Robert Bosch Policy Fellow at the American Academy in Berlin
Author of more than 200 peer reviewed research papers and author/editor of 13 scholarly books
Former Editor-in-Chief of the Academy of Management Perspectives (2 terms)
Deputy Editor of the International Journal for Quality in Health Care
Academic Editor of Medicine®
Associate Editor of the Journal of Technology Transfer
Reviewer for National Academies of Sciences, Engineering and Medicine, National Institutes of Health, and the National Science Foundation
Co-principal investigator (PI) or co-investigator on NIH grants totaling more than US$25 million
Core Director of the Johns Hopkins Artificial Intelligence Technology Collaboratory for Aging Research
Principle Investigator of the National Institutes on Drug Abuse funded Innovation for Substance Use Disorder (I4SUD) program